NCT04836780View on ClinicalTrials.gov

DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia

PHASE3UnknownINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

June 10, 2021

Primary Completion Date

February 28, 2023

Study Completion Date

March 30, 2023

Conditions
COVID-19Acute Respiratory Distress SyndromePneumonia, Viral
Interventions
DRUG

Dexamethasone

Dexamethasone base 6 mg once daily for seven days

Trial Locations (3)

28031

RECRUITING

Hospital Universitario Infanta Leonor, Madrid

28040

RECRUITING

Hospital Universitario Clínico San Carlos, Madrid

28055

RECRUITING

Hospital Emergencias Enfermera Isabel Zendal, Madrid

Sponsors

Collaborators (1)

Kern Pharma, S.L.
All Listed Sponsors
collaborator

Fundación para la Investigación e Innovación Biomédica del Hospital Universitario Infanta Leonor

UNKNOWN

collaborator

Kern Pharma, S.L.

INDUSTRY

lead

Hospital Universitario Infanta Leonor

OTHER